Last Updated:
Create account to add to watchlist!

Atlas Crest Investment Corp. II - ACII

  • Commons



    ACII Vol: 22.0K

  • Warrants



    ACII+ Vol: 1.3K

  • Units



    ACII= Vol: 9.1K

Average: 0
Rating Count: 0
You Rated: Not rated

Please log in to rate.

SPAC Stats

Market Cap: 336.7M
Average Volume: 48.1K
52W Range: $9.46 - $10.37
Weekly %: -0.10%
Monthly %: -0.20%
Inst Owners: 82


Target: Searching
Days Since IPO: 304
Unit composition:
Each unit has an offering price of $10.00 and consists of one share of Class A common stock and one-third of one redeemable warrant
Trust Size: 25000000.0M


Our officers and directors are as follows: Name Age Position Kenneth Moelis 62 Chairman Michael Spellacy 49 Chief Executive Officer and Director Christopher Callesano 47 Chief Financial Officer David Fox 62 Director Nominee Todd Lemkin 45 Director Nominee Emanuel Pearlman 60 Director Nominee Kenneth Moelis has served as the Chairman of our Board of Directors since inception and was our interim Chief Executive Officer from inception to the date of appointment of Mr. Spellacy as Chief Executive Officer. Mr. Moelis is also the Chairman of the Board of Directors of AC I, a blank check company whose sponsor is an affiliate of Moelis & Company. Mr. Moelis is Chairman of the Board of Directors and has served as Chief Executive Officer of Moelis & Company since 2007. Mr. Moelis has almost 40 years of investment banking and mergers and acquisitions experience. Prior to founding our Company, Mr. Moelis founded Moelis, a global independent investment bank, and its affiliate, Moelis Asset Management LP, an alternative asset management firm with approximately $6 billion of assets under management across private equity, direct lending, credit funds, and structured products. Since its inception, Moelis has advised on over $3.5 trillion of transactions including mergers and acquisitions, restructurings and recapitalizations. Mr. Moelis led Moelis’ initial public offering in 2014 while being named EuroMoney’s Banker of the Year. Since its IPO, Moelis has organically grown revenues by over 80% and has generated a total shareholder return of over 200%, including quarterly and special dividends. Prior to founding Moelis, Mr. Moelis worked at UBS from 2001 to 2007, where he was most recently President of UBS Investment Bank and previously Joint Global Head of Investment Banking. Before joining UBS, Mr. Moelis was Head of Corporate Finance at Donaldson, Lufkin & Jenrette, where he worked from 1990 through 2000. Mr. Moelis began his career as an investment banker with Drexel Burnham Lambert in 1981. Mr. Moelis serves on the University of Pennsylvania Board of Trustees, the Wharton Board of Overseers, the Ronald Reagan UCLA Medical Center Board of Advisors and was formerly Chair and Director on the Tourette Association of America Board. Mr. Moelis holds a B.S. and an M.B.A. from the Wharton School at the University of Pennsylvania. Michael Spellacy was appointed our Chief Executive Officer and a director on January 5, 2021. Mr. Spellacy is also the Chief Executive Officer and a director of AC I. Mr. Spellacy has extensive experience in technology, data and analytics, capital markets and private equity and has worked as an investor, investment banker and consultant. Most recently, Mr. Spellacy was a Senior Managing Director at Accenture plc and Global Industry Leader of Accenture Capital Markets while overseeing Accenture’s Asset Management, Wealth Management and Investment and Trading businesses. Accenture plc is a multinational Fortune Global 500 professional services firm with 2020 revenues of over $44 billion. Mr. Spellacy began his role at Accenture in 2017. Prior to Accenture, Mr. Spellacy was a Senior Partner, Asset and Wealth Management, at PricewaterhouseCoopers from 2015 to 2017 and prior to that role, Mr. Spellacy was a Partner at Broadhaven Capital, an industry leading independent investment bank and private equity investor servicing the financial services and technology sectors from 2013 to 2015. Prior to Broadhaven, Mr. Spellacy was a Senior Executive, Management Committee Advisor at Bridgewater Associates, a widely recognized asset manager from 2009 to 2013. Mr. Spellacy led Bridgewater’s $130 billion assets under management transformation program. Prior to Bridgewater, Mr. Spellacy was a Partner and Managing Director at the Boston Consulting Group from 2003 to 2009 where he helped guide the firm’s global Alternative Investments Practice providing strategic business advisory services to global asset managers, sovereign wealth funds and asset owners. He received his B.S. in Economics from the London School of Economics and MBA from the University of Hartford. Christopher Callesano has served as our Chief Financial Officer since inception. Mr. Callesano is also the Chief Financial Officer of AC I. Mr. Callesano is a Managing Director of Moelis and has served as its Principal Accounting Officer since 2016 and its Corporate Controller since 2010. From 2008 to 2010, Mr. Callesano was Senior Managing Director of Financial Reporting and Accounting Policy at NASDAQ OMX where he was responsible for preparing 99 Table of Contents the financial statements filed with the SEC. Previously, Mr. Callesano worked at Merrill Lynch from 2004 to 2008, most recently as Director of Corporate Reporting. Prior to joining Merrill Lynch, Mr. Callesano held various other accounting positions, including as an auditor with Ernst & Young. Mr. Callesano holds a B.S. in Accounting from Penn State University and an M.B.A. in Finance from the Stern School of Business at New York University. He is a Certified Public Accountant licensed in New York State. David Fox is a Director Nominee and is also a director of AC I. Mr. Fox was most recently a senior partner at Kirkland & Ellis LLP from 2009 to 2019 and served as a member of its Global Executive Management Committee. Prior to joining Kirkland, Mr. Fox worked at Skadden, Arps, Slate, Meagher & Flom LLP from 1983 to 2009, where he was most recently a partner and a member of its top governing committee. Mr. Fox is a director of Atrium European Real Estate Limited, Gamida Cell Ltd., Israel Discount Bank of New York and MediWound Ltd. Mr. Fox is also a member of the board of directors at the Park Avenue Armory and a member of the advisory board of New Alternatives for Children, for which he provides crucial support to families caring for medically fragile children. In addition, Mr. Fox is on the board of governors and an honorary fellow of the Hebrew University, Jerusalem, where he received his LLB. We believe Mr. Fox’s extensive transactional and management experience make him well qualified to serve on our board of directors. Todd Lemkin is a Director Nominee and is also a director of AC I. Mr. Lemkin is a Partner and Chief Investment Officer of Canyon Partners, LLC. Mr. Lemkin’s primary focus is on the cable, media, telecom, satellite, real estate, gaming and packaging sectors in the U.S. Mr. Lemkin also oversees Canyon’s European investment effort and the firm’s London office. Prior to joining Canyon in 2003, Mr. Lemkin was with Scoggin Capital Management in New York, where he focused on analyzing securities of distressed and bankrupt companies. Mr. Lemkin was also an Investment Banker in the Healthcare Group of Bank of America Securities and the Mergers & Acquisitions Group of Lehman Brothers. Mr. Lemkin is a graduate of the University of California, Berkeley. We believe Mr. Lemkin’s years of experience investing across a broad range of sectors, his international perspectives and financial structuring expertise make him well qualified to serve on our board of directors. Emanuel Pearlman is a Director Nominee and is also a director of AC I. Mr. Pearlman currently serves as Chairman and Chief Executive Officer of Liberation Investment Group, a New York based investment management and financial consulting firm, which he founded in 2003. He was appointed to the board of AMI 1 LLC, the owner of Associated Materials, Inc., in September 2020. Mr. Pearlman has been a member of the Board of Directors of Network-1 Technologies, Inc. since 2012, where he serves as Chairman of the Audit Committee and a member of the Nominating and Corporate Governance Committee. Mr. Pearlman previously served as a director of Empire Resorts from 2010 to 2019 including as Executive Chairman of the Board from 2016 to 2019 and Non-Executive Chairman of the Board from 2010 to 2016. Mr. Pearlman was a member of the Board of Directors of CEVA Logistics AG from May 2018 to October 2019 and served on its Audit Committee from May 2018 to October 2019 and its Nomination and Governance Committee from May 2018 to May 2019. From 2013 through 2018, he served on the Board of Directors of CEVA Holdings, LLC. From 2018 through 2019, Mr. Pearlman served on the Board of Managers and as President of each of SRC O.P. LLC, SRC Facilities LLC and SRC Real Estate (TX) LLC, which are special purpose bankruptcy remote limited liability companies with ownership of approximately 100 real estate properties of Sears. From May 2017 through September 2017, Mr. Pearlman served on the Board of Directors of ClubCorp Holdings where he served on the Strategic Review Committee, and from 2009 to 2014, he served as the sole independent director of the Fontainebleau Miami JV LLC, which owned and operated the Fontainebleau Hotel in Miami Beach. Mr. Pearlman served as a member of the Board of Directors of Dune Energy from 2012 to 2013 and Jameson Inns, Inc. from January 2012 to December 2012. He also served as a director of Multimedia Games, Inc. from 2006 to 2010. Mr. Pearlman holds an MBA from Harvard Business School and a B.A. in Economics from Duke University. We believe Mr. Pearlman’s broad investing background and extensive board experience make him well qualified to serve on our board of directors. Advisory Board From time to time we may utilize the services of certain advisors and/or form an advisory board consisting of individuals whom we believe will help us execute our business strategy. 100 Table of Contents Number and Terms of Office of Officers and Directors Our board of directors consists of five members and is divided into three classes with only one class of directors being elected in each year, and with each class (except for those directors appointed prior to our first annual meeting of stockholders) serving a three-year term. In accordance with the NYSE corporate governance requirements, we are not required to hold an annual meeting until one year after our first full fiscal year end following our listing on the NYSE. Our officers are appointed by the board of directors and serve at the discretion of the board of directors, rather than for specific terms of office. Our board of directors is authorized to appoint officers as it deems appropriate pursuant to our amended and restated certificate of incorporation. The term of office of the first class of directors, consisting of Mr. Fox, will expire at our first annual meeting of stockholders. The term of office of the second class of directors, consisting of Mr. Lemkin and Mr. Pearlman, will expire at the second annual meeting of stockholders. The term of office of the third class of directors, consisting of Mr. Moelis and Mr. Spellacy, will expire at the third annual meeting of stockholders. Director Independence The NYSE listing standards require that a majority of our board of directors be independent. An “independent director” is defined generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having a relationship which in the opinion of the company’s board of directors, would interfere with the director’s exercise of independent judgment in carrying out the responsibilities of a director. We expect that our board of directors will determine that Messrs. Fox, Lemkin and Pearlman are “independent directors” as defined in the NYSE listing standards and applicable SEC rules. Our independent directors will have regularly scheduled meetings at which only independent directors are present. Executive Officer and Director Compensation None of our directors have received any cash compensation for services rendered to us. Commencing on the date that our securities are first listed on the NYSE through the earlier of consummation of our initial business combination and our liquidation, we will pay to Moelis & Company LLC $10,000 per month for executive, corporate development and other operational support, including accounting and legal services, and office space provided to members of our management team. We and the Sponsor have agreed to indemnify Moelis & Company LLC and its affiliates in connection with the services provided pursuant to the services agreement. Moelis & Company LLC has agreed to waive any right, title, interest or claim of any kind in or to any monies in the trust account, and not to seek recourse against the trust account with respect to the indemnification obligations set forth in the services agreement. In addition, our sponsor, executive officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. Our audit committee will review on a quarterly basis all payments that were made to our sponsor, executive officers or directors, or our or their affiliates. Any such payments prior to an initial business combination will be made from funds held outside the trust account. Other than quarterly audit committee review of such reimbursements, we do not expect to have any additional controls in place governing our reimbursement payments to our directors and executive officers for their out-of-pocket expenses incurred in connection with our activities on our behalf in connection with identifying and consummating an initial business combination. No compensation of any kind, including finder’s and consulting fees, will be paid by the company to our sponsor, executive officers and directors, or any of their respective affiliates, prior to completion of our initial business combination except for these payments and reimbursements. In addition, we will pay Moelis & Company LLC a portion of the Marketing Fee upon the consummation of our initial business combination and we may engage Moelis as a financial advisor in connection with our initial business combination and pay such affiliate customary financial advisory fees in an amount that constitutes a market standard financial advisory fee for comparable transactions. After the completion of our initial business combination, directors or members of our management team who remain with us may be paid consulting or management fees from the combined company. All of these fees will be fully disclosed to stockholders, to the extent then known, in the proxy solicitation materials or tender offer materials furnished to our stockholders in connection with a proposed business combination. We have not established any limit on the amount of such fees that may be paid by the combined company to our directors or members of management. It is unlikely the 101 Table of Contents amount of such compensation will be known at the time of the proposed business combination, because the directors of the post-combination business will be responsible for determining executive officer and director compensation. Any compensation to be paid to our executive officers will be determined, or recommended to the board of directors for determination, either by a compensation committee constituted solely by independent directors or by a majority of the independent directors on our board of directors. We do not intend to take any action to ensure that members of our management team maintain their positions with us after the consummation of our initial business combination, although it is possible that some or all of our executive officers and directors may negotiate employment or consulting arrangements to remain with us after our initial business combination. The existence or terms of any such employment or consulting arrangements to retain their positions with us may influence our management’s motivation in identifying or selecting a target business but we do not believe that the ability of our management team to remain with us after the consummation of our initial business combination will be a determining factor in our decision to proceed with any potential business combination. We are not party to any agreements with our executive officers and directors that provide for benefits upon termination of employment. Committees of the Board of Directors Our board of directors will have three standing committees: an audit committee, a compensation committee and a nominating and corporate governance committee. Subject to phase-in rules and a limited exception, the NYSE rules and Rule 10A-3 of the Exchange Act require that the audit committee of a listed company be comprised solely of independent directors. Subject to phase-in rules and a limited exception, the NYSE rules require that the compensation committee and nominating and corporate governance committee of a listed company be comprised solely of independent directors. Audit Committee Upon the effectiveness of the registration statement of which this prospectus forms a part, we will establish an audit committee of the board of directors. Messrs. Fox, Lemkin and Pearlman will serve as members of our audit committee, and Mr. Pearlman will chair the audit committee. All members of our audit committee are independent of and unaffiliated with our sponsor and our underwriters. Each member of the audit committee is financially literate and our board of directors has determined that Mr. Pearlman qualifies as an “audit committee financial expert” as defined in applicable SEC rules and has accounting or related financial management expertise. We will adopt an audit committee charter, which will detail the principal functions of the audit committee, including: • assisting board oversight of (1) the integrity of our financial statements, (2) our compliance with legal and regulatory requirements, (3) our independent registered public accounting firm’s qualifications and independence, and (4) the performance of our internal audit function and independent registered public accounting firm; the appointment, compensation, retention, replacement, and oversight of the work of the independent auditors and any other independent registered public accounting firm engaged by us; • pre-approving all audit and non-audit services to be provided by the independent auditors or any other registered public accounting firm engaged by us, and establishing pre-approval policies and procedures; reviewing and discussing with the independent registered public accounting firm all relationships the auditors have with us in order to evaluate their continued independence; • setting clear policies for audit partner rotation in compliance with applicable laws and regulations; obtaining and reviewing a report, at least annually, from the independent registered public accounting firm describing (1) the independent registered public accounting firm’s internal quality-control procedures and (2) any material issues raised by the most recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities, within the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues; 102 Table of Contents • meeting to review and discuss our annual audited financial statements and quarterly financial statements with management and the independent auditor, including reviewing our specific disclosures under “Management’s Discussion and Analysis of Financial Condition and Results of Operations”; reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and • reviewing with management, the independent, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or

Holder Stats

1 0
% of Shares Held by All Insider 0.00%
% of Shares Held by Institutions 61.06%
% of Float Held by Institutions 61.06%
Number of Institutions Holding Shares 82

Mutual Fund Holders

Holder Shares Date Reported Value % Out
Collaborative Inv Ser Tr-SPAC and New Issue ETF 119909 2021-06-29 1169112 0.35000000000000003
AQR Funds-AQR Diversified Arbitrage Fd 82464 2021-06-29 804024 0.24
Franklin K2 Alternative Strategies Fd 20011 2021-05-30 194907 0.06
RiverNorth Opportunities Fd 4192 2021-07-30 40662 0.01

Institutional Holders

Reporting Date Hedge Fund Shares Held Market Value % of Portfolio Quarterly Change in Shares Ownership in Company
2021-11-16 Whitebox Advisors LLC 75,000 $730,000 0.0% +44.5% 0.174%
2021-11-15 Omni Partners US LLC 52,614 $510,000 0.0% -2.6% 0.122%
2021-11-15 Highbridge Capital Management LLC 2,215,466 $21,620,000 0.6% +37.4% 5.137%
2021-11-15 HighTower Advisors LLC 511,695 $5,000,000 0.0% -9.5% 1.187%
2021-11-12 OLD Mission Capital LLC 10,057 $98,000 0.0% 0 0.023%
2021-11-10 MMCAP International Inc. SPC 650,000 $6,340,000 0.4% -18.3% 1.507%
2021-10-22 Tuttle Capital Management LLC 117,301 $900,000 0.4% -25.6% 0.272%
2021-08-17 Basswood Capital Management L.L.C. 161,773 $1,580,000 0.1% -18.0% 0.375%
2021-08-16 Whitebox Advisors LLC 51,900 $510,000 0.0% +3.8% 0.120%
2021-08-16 Bank of America Corp DE 100,000 $980,000 0.0% 0 0.232%
2021-08-13 Qube Research & Technologies Ltd 20,272 $200,000 0.0% 0 0.047%
2021-08-12 Highbridge Capital Management LLC 1,612,823 $15,730,000 0.4% +208.8% 3.740%
2021-08-06 HighTower Advisors LLC 565,267 $5,520,000 0.0% 0 1.311%
2021-07-31 Tuttle Tactical Management 157,657 $1,210,000 0.5% -1.1% 0.366%
2021-07-31 Sanders Morris Harris LLC 17,492 $170,000 0.0% 0 0.041%
2021-07-28 Cohen & Co Financial Management LLC 500,000 $4,880,000 3.1% 0 1.159%
2021-05-18 Bluefin Capital Management LLC 29,536 $300,000 0.0% 0 0.068%
2021-05-18 Owl Creek Asset Management L.P. 20,000 $200,000 0.0% 0 0.046%
2021-04-21 Deltec Asset Management LLC 75,000 $730,000 0.1% 0 0.174%

SEC Filings

Form Type Form Description Filing Date Document Link
8-K FORM 8-K 2021-11-29
10-Q FORM 10-Q 2021-11-05
8-K FORM 8-K 2021-10-20
10-Q FORM 10-Q 2021-08-16
UPLOAD 2021-05-25
CORRESP 2021-05-24
8-K/A FORM 8-K/A 2021-05-24
10-Q 10-Q 2021-05-24
UPLOAD 2021-05-17
NT 10-Q NT 10-Q 2021-05-17
8-K FORM 8-K 2021-05-17
10-K FORM 10-K 2021-03-29
8-K CURRENT REPORT 2021-03-26
8-K CURRENT REPORT 2021-02-12
8-K CURRENT REPORT 2021-02-09
424B4 2021-02-08
EFFECT 2021-02-03
3 2021-02-03
3 2021-02-03
3 2021-02-03
3 2021-02-03
3 2021-02-03
3 2021-02-03
3 2021-02-03
S-1/A AMENDMENT NO. 1 TO FORM S-1 2021-02-01